Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry.
Marco ProiettiGiulio Francesco RomitiMarco VitoloTatjana S PotparaGiuseppe BorianiGregory Y H LipPublished in: European heart journal. Quality of care & clinical outcomes (2021)
In this real-life contemporary cohort of AF patients treated with NOACs, the ORBIT score did not provide reclassification improvement, showing even poorer calibration compared to HAS-BLED. Our findings do not support the preferential use of ORBIT in NOAC-treated AF patients.